Tag: immunotherapy
UQ researchers develop nanotech to boost immunotherapy for breast cancer
Researchers at the University of Queensland are developing nanotechnology that could enhance the effectiveness of treatments for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease.
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
